<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; still</title>
	<atom:link href="http://www.tapanray.in/tag/still/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Access to affordable healthcare to 65% of Indian population still remains a key issue even after six decades of independence of the country.</title>
		<link>http://www.tapanray.in/access-to-affordable-healthcare-to-65-of-indian-population-still-remains-a-key-issue-even-after-six-decades-of-independence-of-the-country/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=access-to-affordable-healthcare-to-65-of-indian-population-still-remains-a-key-issue-even-after-six-decades-of-independence-of-the-country</link>
		<comments>http://www.tapanray.in/access-to-affordable-healthcare-to-65-of-indian-population-still-remains-a-key-issue-even-after-six-decades-of-independence-of-the-country/#comments</comments>
		<pubDate>Mon, 12 Apr 2010 01:30:02 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[65%]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[affordable]]></category>
		<category><![CDATA[after]]></category>
		<category><![CDATA[Country]]></category>
		<category><![CDATA[decades]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Even]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[independence]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[issue]]></category>
		<category><![CDATA[key]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[remains]]></category>
		<category><![CDATA[six]]></category>
		<category><![CDATA[still]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=442</guid>
		<description><![CDATA[Despite so much of stringent government control, debate and activism on the affordability of modern medicines in India, on the one hand, and the success of the government to make medicines available in the country at a price, which is &#8230; <a href="http://www.tapanray.in/access-to-affordable-healthcare-to-65-of-indian-population-still-remains-a-key-issue-even-after-six-decades-of-independence-of-the-country/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/access-to-affordable-healthcare-to-65-of-indian-population-still-remains-a-key-issue-even-after-six-decades-of-independence-of-the-country/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Indian Patent offices (IPOs) have started showing improvement in their functioning; still lot of grounds to cover.</title>
		<link>http://www.tapanray.in/indian-patent-offices-ipos-have-started-showing-improvement-in-their-functioning-still-lot-of-grounds-to-cover/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=indian-patent-offices-ipos-have-started-showing-improvement-in-their-functioning-still-lot-of-grounds-to-cover</link>
		<comments>http://www.tapanray.in/indian-patent-offices-ipos-have-started-showing-improvement-in-their-functioning-still-lot-of-grounds-to-cover/#comments</comments>
		<pubDate>Thu, 10 Dec 2009 01:00:44 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2005]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[CGPDTM]]></category>
		<category><![CDATA[cover]]></category>
		<category><![CDATA[functioning]]></category>
		<category><![CDATA[grounds]]></category>
		<category><![CDATA[Have]]></category>
		<category><![CDATA[improvement]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[IPO]]></category>
		<category><![CDATA[it]]></category>
		<category><![CDATA[lot]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[offices]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[showing]]></category>
		<category><![CDATA[started]]></category>
		<category><![CDATA[still]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[their]]></category>
		<category><![CDATA[to]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=700</guid>
		<description><![CDATA[Indian Patent offices are located, with four clearly specified jurisdictions, at New Delhi, Mumbai, Kolkata and Chennai. Since last few years enough efforts have been made towards overall capacity building initiatives, training of personnel and digitalizing the huge databank of &#8230; <a href="http://www.tapanray.in/indian-patent-offices-ipos-have-started-showing-improvement-in-their-functioning-still-lot-of-grounds-to-cover/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/indian-patent-offices-ipos-have-started-showing-improvement-in-their-functioning-still-lot-of-grounds-to-cover/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>To prevent ‘counterfeit medicines’ from reaching the patients is the nation&#8217;s public health responsibility: Are we still in a denial mode to even accept the existence of this public health menace?</title>
		<link>http://www.tapanray.in/to-prevent-counterfeit-medicines-from-reaching-the-patients-is-the-nations-public-health-responsibility-are-we-still-in-a-denial-mode-to-even-accept-the-existence-of-this-public-h/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=to-prevent-counterfeit-medicines-from-reaching-the-patients-is-the-nations-public-health-responsibility-are-we-still-in-a-denial-mode-to-even-accept-the-existence-of-this-public-h</link>
		<comments>http://www.tapanray.in/to-prevent-counterfeit-medicines-from-reaching-the-patients-is-the-nations-public-health-responsibility-are-we-still-in-a-denial-mode-to-even-accept-the-existence-of-this-public-h/#comments</comments>
		<pubDate>Thu, 19 Nov 2009 01:00:00 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[accept]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[DCGI]]></category>
		<category><![CDATA[denial]]></category>
		<category><![CDATA[Even]]></category>
		<category><![CDATA[existence]]></category>
		<category><![CDATA[From]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[Ministry]]></category>
		<category><![CDATA[mode]]></category>
		<category><![CDATA[MoH]]></category>
		<category><![CDATA[nation]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[prevent]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reaching]]></category>
		<category><![CDATA[responsibility]]></category>
		<category><![CDATA[still]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[this]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=721</guid>
		<description><![CDATA[In November 7, 2009, Financial Express reported with a headline,”Generic drug companies see a bitter pill in counterfeit&#8220;, because some believe that it has an in-built intellectual property right connotation. The dictionary definition: The word ‘counterfeit’ may be defined as &#8230; <a href="http://www.tapanray.in/to-prevent-counterfeit-medicines-from-reaching-the-patients-is-the-nations-public-health-responsibility-are-we-still-in-a-denial-mode-to-even-accept-the-existence-of-this-public-h/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/to-prevent-counterfeit-medicines-from-reaching-the-patients-is-the-nations-public-health-responsibility-are-we-still-in-a-denial-mode-to-even-accept-the-existence-of-this-public-h/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Provision for Compulsory Licensing (CL) in India – some issues still need to be addressed.</title>
		<link>http://www.tapanray.in/provision-for-compulsory-licensing-cl-in-india-some-issues-still-need-to-be-addressed/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=provision-for-compulsory-licensing-cl-in-india-some-issues-still-need-to-be-addressed</link>
		<comments>http://www.tapanray.in/provision-for-compulsory-licensing-cl-in-india-some-issues-still-need-to-be-addressed/#comments</comments>
		<pubDate>Thu, 05 Nov 2009 02:00:44 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[100%]]></category>
		<category><![CDATA[2005]]></category>
		<category><![CDATA[84]]></category>
		<category><![CDATA[87]]></category>
		<category><![CDATA[92]]></category>
		<category><![CDATA[92A]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[addressed]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[be]]></category>
		<category><![CDATA[CL]]></category>
		<category><![CDATA[Compulsory]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Issues]]></category>
		<category><![CDATA[Licensing]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[Provision]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[sections]]></category>
		<category><![CDATA[still]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[working]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=736</guid>
		<description><![CDATA[Patent law systems provide for a provision for granting of compulsory licenses in a number of circumstances. Article 5A(2) of The Paris Convention, 1883 indicates that each contracting State may take legislative measures for the grant of compulsory licenses and &#8230; <a href="http://www.tapanray.in/provision-for-compulsory-licensing-cl-in-india-some-issues-still-need-to-be-addressed/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/provision-for-compulsory-licensing-cl-in-india-some-issues-still-need-to-be-addressed/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Key business strategies of global pharmaceutical industry are undergoing a radical change, while in India we are still thinking within the box. Who cares about the global clue?</title>
		<link>http://www.tapanray.in/key-business-strategies-of-global-pharmaceutical-industry-are-undergoing-a-radical-change-while-in-india-we-are-still-thinking-within-the-box-who-cares-about-the-global-clue/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=key-business-strategies-of-global-pharmaceutical-industry-are-undergoing-a-radical-change-while-in-india-we-are-still-thinking-within-the-box-who-cares-about-the-global-clue</link>
		<comments>http://www.tapanray.in/key-business-strategies-of-global-pharmaceutical-industry-are-undergoing-a-radical-change-while-in-india-we-are-still-thinking-within-the-box-who-cares-about-the-global-clue/#comments</comments>
		<pubDate>Thu, 14 May 2009 04:23:27 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[about]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[box]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[cares]]></category>
		<category><![CDATA[Change]]></category>
		<category><![CDATA[clue]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[key]]></category>
		<category><![CDATA[Key business strategies of global pharmaceutical industry are undergoing a radical change]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[radical]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[still]]></category>
		<category><![CDATA[strategies]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[thinking]]></category>
		<category><![CDATA[undergoing]]></category>
		<category><![CDATA[we]]></category>
		<category><![CDATA[while]]></category>
		<category><![CDATA[while in India we are still thinking within the box. Who cares about the global clue]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[within]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=887</guid>
		<description><![CDATA[One of the leading consulting companies, PricewaterhouseCoopers (PwC) in its report of June 2007 titled “Pharma 2020: The vision –Which path will you take?” postulated that the business model followed by the global pharmaceutical companies is, “economically unsustainable and operationally &#8230; <a href="http://www.tapanray.in/key-business-strategies-of-global-pharmaceutical-industry-are-undergoing-a-radical-change-while-in-india-we-are-still-thinking-within-the-box-who-cares-about-the-global-clue/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/key-business-strategies-of-global-pharmaceutical-industry-are-undergoing-a-radical-change-while-in-india-we-are-still-thinking-within-the-box-who-cares-about-the-global-clue/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Growing menace of counterfeit drugs in India: why is the domestic pharmaceutical industry still so apprehensive with the new Amendments of the ACT?</title>
		<link>http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2</link>
		<comments>http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/#comments</comments>
		<pubDate>Wed, 29 Apr 2009 00:30:15 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[Amendments]]></category>
		<category><![CDATA[apprehensive]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[domestic]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Growing]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[so]]></category>
		<category><![CDATA[still]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[why]]></category>
		<category><![CDATA[with]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=903</guid>
		<description><![CDATA[The growing menace of Counterfeit drugs has remained a serious threat to the healthcare space of India. Do we have any credible data to assess the magnitude of this menace in India? No we do not have, as yet. At &#8230; <a href="http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
